About Ra Chem Pharma Limited
Data last updated:
Ra Chem Pharma Limited was a public limited company based in Hyderabad, Andhra Pradesh, India, operated as a subsidiary of Ai Pharmed Consultancy India Limited. The company has been amalgamated - it was merged with another entity and no longer exists as a separate legal entity. It operated in the API manufacturers segment of the pharmaceuticals sector. It was incorporated on 08 January 1996.
The company was registered with the Registrar of Companies (ROC), Hyderabad, under CIN U24110TG1996PLC022816. Its GSTIN is 36AAACI6448M1Z6 (Telangana). The company held 3 GST registrations, all of them active.
The company had an authorised share capital of ₹29.1 Cr and a paid-up capital of ₹8.5 Cr. It was formerly known as Igor Dyespec Private Limited and Igor Pharmachem Limited. It was led by directors including Venkatanaga Kali Vetukuri Vara Prasada Raju (Managing Director) and Shweta Jalan.
Its last annual general meeting (AGM) was held on 29 September 2021, and its latest financial statements are for the year ended 31 March 2021. The registered office was at Hyderabad, Andhra Pradesh.
As per the financials filed for FY 2021, the company reported a revenue of ₹621.32 Cr, a growth of 15% compared to the previous year. For the same year it recorded a net profit of ₹77.8 Cr (net margin 12.5%) and EBITDA of ₹131.74 Cr (EBITDA margin 21.2%). Revenue has grown at a compounded annual rate (CAGR) of 12% over three years.
The company had about 1,138 employees on its provident fund (EPFO) records before it was dissolved.
The company was associated with 1 brand: Ra Chem Pharma. As per MCA filings, the company had open charges of ₹40 Cr and satisfied charges of ₹802.55 Cr on record. Court records list 29 cases involving the company, including 14 filed by the company and 15 filed against it. The company has 35 deals on record (21 secondary share transfers, 13 funding rounds, 1 acquisition), with disclosed funding of ₹19.27 Cr; the latest was in December 2020. Its 5 peer companies in the Pharma industry (API Manufacturers, Contract Research, Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products) are compared by revenue, 3 larger and 2 smaller; the largest is Theon Pharmaceuticals Limited with revenue of ₹633.1 Cr. The company has 15 MSME Form 1 returns on record between 2019 and 2022, listing 3,854 overdue payments to 333 micro and small suppliers.
The last known website on record is rachempharma.com.
Company details
Name history
Ra Chem Pharma has undergone 3 name changes throughout its history. The company was previously known as Igor Dyespec Private Limited, Igor Pharmachem Limited, and Igor Pharmachem Private Limited. The current legal name is Ra Chem Pharma Limited.
| Company Name | Status |
|---|---|
| Ra Chem Pharma Limited | Current |
| Igor Dyespec Private Limited | Previous |
| Igor Pharmachem Limited | Previous |
| Igor Pharmachem Private Limited | Previous |
CIN history
Ra Chem Pharma has one previous CIN (Corporate Identification Number): U24110AP1996PLC022816. The current CIN is U24110TG1996PLC022816, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U24110TG1996PLC022816 | Current |
| U24110AP1996PLC022816 | Previous |
Contact details
Ra Chem Pharma Limited's registered office is in Hyderabad, Andhra Pradesh. Its website is rachempharma.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered AddressPlot No 26 27 Technocrats Industrial Estate Phase I Balanagar, India, Hyderabad, Andhra Pradesh, India – 500037
- IndustryPharma, API Manufacturers, Pharma Contract R&D, Drug Formulation & Development
To see the full contact details of Ra Chem Pharma Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Brands
Ra Chem Pharma operates one associated brand: Ra Chem Pharma. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| API and formulations are developed and manufactured under contract. | rachempharma.com |
Business activity
The main business activity of Ra Chem Pharma is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Ra Chem Pharma Limited, buy the company report.
Financials of Ra Chem Pharma Limited
FY 2021 filings availableRa Chem Pharma Limited reported revenue of ₹621.32 Cr (up 15% YoY) for FY 2021.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 12% over three years, including 15% growth in the latest year. EBITDA fell 9% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2020-21 | FY 2019-20 | FY 2018-19 | FY 2017-18 | FY 2016-17 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | ₹621.32 Cr | ||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹131.74 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹77.8 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2020-21 | FY 2019-20 | FY 2018-19 | FY 2017-18 | FY 2016-17 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 21.2% | ||||
| Net Profit Margin | 12.5% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Ra Chem Pharma Limited, buy the company report.
Board of directors and KMP of Ra Chem Pharma Limited
Ra Chem Pharma Limited currently reports 6 directors and 1 key managerial person. 24 former directors have served the organization.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Shweta Jalan Also directs: Cohance Lifesciences Limited, Coforge Limited, Modenik Lifestyle Private Limited and 1 more | Director | 27 Oct 2020 | 6 Years 0 Months | As last reported |
| Abhijit Mangalmoy Mukherjee | Director | 27 Oct 2020 | 6 Years 0 Months | As last reported |
| Venkatanaga Kali Vetukuri Vara Prasada Raju Also directs: Deccan Fine Chemicals (India) Private Limited | Managing Director | 10 Mar 2021 | 5 Years 7 Months | As last reported |
| Jayant Bhalchandra Manmadkar | Cfo | 16 Jul 2021 | 5 Years 3 Months | As last reported |
| Pankaj Patwari Also directs: Cohance Lifesciences Limited, Keimed Private Limited, Advent India Pe Advisors Private Limited and 1 more | Director | 27 Oct 2020 | 6 Years 0 Months | As last reported |
| Anil Kumar Chanana | Additional Director | 15 Dec 2021 | 4 Years 10 Months | As last reported |
Peer comparison
Ra Chem Pharma Limited is compared with the 5 companies closest to it by revenue in the Pharma industry (API Manufacturers, Contract Research, Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Theon Pharmaceuticals Limited | ₹633.1 Cr (FY 2025) | 4.0% | Chandigarh, India | |||
| Malladi Drugs and Pharmaceuticals Limited | ₹626.79 Cr (FY 2025) | -7.0% | Chennai, Tamil Nadu, India | |||
| Samarth Life Sciences Private Limited | ₹624.79 Cr (FY 2025) | 11.0% | Mumbai, Maharashtra, India | |||
| Ra Chem Pharma Limitedthis company | ₹621.32 Cr (FY 2021) | ₹77.8 Cr | 12.5% | 15.0% | 1,138 | Hyderabad, Andhra Pradesh, India |
| Inventia Healthcare Limited | ₹620.73 Cr (FY 2025) | -19.0% | Mumbai, Maharashtra, India | |||
| Sri Krishna Pharmaceuticals Limited | ₹608.24 Cr (FY 2025) | -13.0% | Telangana, India |
To see the full peer comparison of Ra Chem Pharma Limited, buy the company report.
Auditor
Ra Chem Pharma Limited is audited by Walker Chandiok & Co LLP for the financial year 2021.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| Walker Chandiok & Co LLP | FY 2021 | 001076N/N500013 |
Shareholding
The shareholding of Ra Chem Pharma Limited is on record for 5 financial years, the latest being FY 2021, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Ra Chem Pharma Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 25 Jul 2018 | 100203658 | Others | ₹20 Cr | Open | |
| 30 Jan 2018 | 100154322 | Others | ₹20 Cr | Open | |
| 13 Mar 2020 | 100332061 | Axis Bank Limited | ₹52 Cr | Satisfied | |
| 30 Jan 2018 | 100154276 | Others | ₹10.6 Cr | Satisfied | |
| 30 Jan 2018 | 100154793 | Others | ₹27 Cr | Satisfied |
To see the full charge records of Ra Chem Pharma Limited, buy the company report.
Total charge records: 31 View all charges
Deals & funding
Ra Chem Pharma Limited has 35 deals on record (21 secondary share transfers, 13 funding rounds, 1 acquisition), with disclosed funding of ₹19.27 Cr; the latest was in December 2020.
Deals on record (5 of 35)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Dec 2020 | Secondary share transfer | Undisclosed | Buyer: Micro Labs Limited Seller: 2 individuals |
| Dec 2020 | Secondary share transfer | Undisclosed | Buyer: Micro Labs Limited Seller: an individual |
| Dec 2020 | Secondary share transfer | Undisclosed | Buyer: Micro Labs Limited Seller: an individual |
| Oct 2020 | Acquisition | ₹769.9 Cr | Buyer: Advent India PE Advisors Seller: Micro Labs Limited |
| Oct 2020 | Secondary share transfer | Undisclosed | Buyer: Micro Labs Limited Seller: 2 individuals |
To see the full deal history of Ra Chem Pharma Limited, buy the company report.
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
Ra Chem Pharma Limited has 29 court cases on record: 14 filed by Ra Chem Pharma, 15 filed against it. All cases are disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 14 | 4 | 0 |
| District courts | 13 | 10 | 0 |
| Supreme Court | 1 | 1 | 0 |
| NCLT | 1 | 0 | 0 |
Cases on record (5 of 29)
| Court | Type of case | Party | Status |
|---|---|---|---|
| High Court for State of Telangana | Writ petition | Filed by the company against Icici Bank Ltd. and 1 other | Disposed |
| Bombay High Court | Arbitration matter | Filed against the company by Olive Healthcare | Disposed |
| District court, Medchal Malkajgiri, Telangana | Criminal complaint | Filed by the company against Vidhya Pharma Chem Pvt Ltd | Disposed |
| District court, Jalgaon, Maharashtra | Civil suit | Filed against the company by Benzo Chem Industries Pvt.Ltd Jalgaon | Disposed |
| District court, Rangareddy, Telangana | Civil suit | Filed against the company by Ms Nile Ltd Rep by Its Director (Finance), | Disposed |
To see the full case history of Ra Chem Pharma Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
Credit ratings & regulatory alerts
Ra Chem Pharma Limited was last rated by Care on 06 Jul 2021.
| Rating agency | Rated on | Rating |
|---|---|---|
| Care | 06 Jul 2021 |
To see the full credit ratings and regulatory alerts of Ra Chem Pharma Limited, buy the company report.
MSME payment delays
Ra Chem Pharma Limited has 15 MSME Form 1 returns on record between 2019 and 2022, listing 3,854 overdue payments to 333 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (5 of 333)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| Lab Needs | |||
| an individual supplier | |||
| Production Needs Gases Private Limited | |||
| an individual supplier | |||
| Sri Sri Sai Ram Print Pack |
To see the full MSME payment records of Ra Chem Pharma Limited, buy the company report.
Individuals and sole proprietors among the suppliers are not named.
Employees & EPFO
Ra Chem Pharma Limited has a workforce of 1,138 employees on its EPFO records as of Apr 05, 2024, across 3 active EPFO establishments.
GST
Ra Chem Pharma has 3 GST registrations: 3 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 36AAACI6448M1Z6 | Telangana | Active | 01 Jul 2017 |
| 36AAACI6448M2Z5 | Telangana | Active | 01 Aug 2018 |
| 37AAACI6448M1Z4 | Andhra Pradesh | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Ra Chem Pharma Limited, buy the company report.
Recent activity
Ra Chem Pharma Limited has 31 board changes on record since 2012: 7 appointments and 24 cessations. The latest: Ashok Kumar Jain ceased to be Director on 19 Aug 2022.
96 earlier events are in the company report.
Frequently asked questions
Ra Chem Pharma has been "Amalgamated" (merged) as per MCA records. The company was combined with another entity and no longer exists as a separate legal entity. Business activities, if any, continue under the successor entity.
Ra Chem Pharma was a public limited company based in Hyderabad, Andhra Pradesh, India. The company worked in api manufacturers, within the pharma industry. It was incorporated on 08 January 1996 and is registered under CIN U24110TG1996PLC022816. The company is recorded as amalgamated in MCA records and no longer exists as a legal entity.
Ra Chem Pharma was incorporated on 08 January 1996. It is registered with the Registrar of Companies, Hyderabad.
Ra Chem Pharma had 7 directors and KMP:
- Venkatanaga Kali Vetukuri Vara Prasada Raju - Managing Director
- Shweta Jalan - Director
- Abhijit Mangalmoy Mukherjee - Director
- Pankaj Patwari - Director
- Anil Kumar Chanana - Additional Director
- Bhaskar Vemban Iyer - Director
- Jayant Bhalchandra Manmadkar - Cfo
The CIN (Corporate Identification Number) of Ra Chem Pharma is U24110TG1996PLC022816. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
The registered office of Ra Chem Pharma is at Plot No 26 27 Technocrats Industrial Estate Phase I Balanagar, India, Hyderabad, Andhra Pradesh, India – 500037.
Ra Chem Pharma can be reached through the website rachempharma.com. Its registered office is in Hyderabad, Andhra Pradesh, India.
The latest financial statements of Ra Chem Pharma on record with the MCA are for the year ended 31 March 2021. Its last annual general meeting was held on 29 September 2021. Year-wise statements from 2015 are in the company report.
The GSTIN of Ra Chem Pharma is 36AAACI6448M1Z6, registered in Telangana. The company has 3 GST registrations in all, of which 3 are active. Other active GSTINs include 36AAACI6448M2Z5 (Telangana), 37AAACI6448M1Z4 (Andhra Pradesh).
Ra Chem Pharma operated in the pharma industry, in the api manufacturers segment.
Ra Chem Pharma has 35 deals on record (21 secondary share transfers, 13 funding rounds, 1 acquisition), with disclosed funding of ₹19.27 Cr; the latest was in December 2020.
The peers of Ra Chem Pharma by revenue are Theon Pharmaceuticals Limited, Malladi Drugs and Pharmaceuticals Limited, Samarth Life Sciences Private Limited, Inventia Healthcare Limited, Sri Krishna Pharmaceuticals Limited, all in the Pharma industry (API Manufacturers, Contract Research, Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
